Autoimmune Diseases  >>  pateclizumab (RG7416)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pateclizumab (RG7416) / Roche
NCT00888745: A Study of the Safety and Pharmacokinetics of PRO283698 in Patients With Rheumatoid Arthritis

Checkmark P1 data: ASI 2012 (RA)
Nov 2012 - Nov 2012: P1 data: ASI 2012 (RA)
Completed
1
65
US, Europe
placebo, PRO283698
Genentech, Inc.
Rheumatoid Arthritis
06/10
 

Download Options